NICE recommends SGLT-2 inhibitors with metformin at diagnosis, citing major cardiovascular, renal, and mortality benefits.

Physicians must deploy specific tools in specific ways at specific times — adding to the time-consuming treatment costs.

Dr. Ahn shares how diabetology fellowships can help health systems expand specialty diabetes care amid rising demand.

Please provide your email address to receive an email when new articles are posted on . “Upon nursing home admission, the admitting clinician assesses the appropriateness of each medication in context ...

A free educational webinar, open to the public, about living with diabetes and how diabetes impacts vision is set for March ...

The new NICE guidance recommends that most people should now be offered metformin along with an SGLT-2 inhibitor from the start, while also advising that they get a slow-release formulation of ...